It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
China starts testing coronavirus nasal spray vaccine

World / Science & Health Sep 11, 2020

China starts testing coronavirus nasal spray vaccine

Some scientists hope a vaccine that gets sprayed through the nose may have a better chance of stopping the spread of the insidious virus through respiratory tracts.

Vaccine politics demand more from big pharma

Commentary / World Sep 9, 2020

Vaccine politics demand more from big pharma

by Max Nisen

The FDA usually wants high standards while drugmakers push boundaries. But political pressure and public unease over a rushed process has forced a role reversal.

Race for coronavirus vaccine pits spy against spy

World Sep 6, 2020

Race for coronavirus vaccine pits spy against spy

The pandemic has prompted one of the fastest peacetime mission shifts in recent times for the world’s intelligence agencies, pitting them against one another.

COVID-19 vaccine front-runners will soon see their moment of truth

World / Science & Health Sep 3, 2020

COVID-19 vaccine front-runners will soon see their moment of truth

Early safety data is key; unlike drugs, vaccines are typically given to relatively healthy people and shouldn’t create severe risks.

Vaccine front-runner held back by China’s spat with Canada

Asia Pacific / Science & Health Sep 2, 2020

Vaccine front-runner held back by China’s spat with Canada

One of the world’s fastest-moving efforts to develop a COVID-19 vaccine is falling behind rivals, its advance appearing to be stymied by political tensions between China and Canada and concerns its shot may not work as well as others. CanSino Biologics Inc., the Chinese company ...

Japan to join international framework to procure coronavirus vaccine

National / Science & Health Sep 1, 2020

Japan to join international framework to procure coronavirus vaccine

The government will consider financially supporting the development of nine potential vaccines that are currently in the second to third stages of clinical trials.

Scientists see downsides to top COVID-19 vaccines from Russia and China

World / Science & Health | FOCUS Aug 31, 2020

Scientists see downsides to top COVID-19 vaccines from Russia and China

by Allison Martell and Julie Steenhuysen

High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say. CanSino Biologics' vaccine, approved for military use in China, is a ...

National / Science & Health Aug 31, 2020

Daiichi Sankyo's COVID-19 vaccine candidate selected by Japanese drug discovery body

Daiichi Sankyo Co. said on Monday that its mRNA-based COVID-19 vaccine candidate was selected for inclusion in a drug discovery program by the Japan Agency for Medical Research and Development. The vaccine, known as DS-5670, was picked for the second round of AMED's program dedicated ...

Abe vows COVID-19 vaccinations for all Japan citizens by mid-2021

National / Social Issues Aug 28, 2020

Abe vows COVID-19 vaccinations for all Japan citizens by mid-2021

by Ryusei Takahashi

In view of the coming flu season, test kits will be provided at a volume that will allow for an average of 200,000 tests to be conducted every day.

Takeda to sell consumer unit to Blackstone for ¥242 billion

Business / Corporate Aug 24, 2020

Takeda to sell consumer unit to Blackstone for ¥242 billion

Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health care business for ¥242 billion ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years. For the drugmaker, the sale could represent one of the last ...

Takeda on track to sell OTC drug unit to Blackstone for ¥300 billion

Business Aug 19, 2020

Takeda on track to sell OTC drug unit to Blackstone for ¥300 billion

Takeda is aiming to reduce debts after its purchase of Irish drugmaker Shire in January last year, the largest-ever Japanese acquisition of a foreign company.

Philippines begins nine-month clinical trial on Avigan in COVID-19 study

National / Science & Health Aug 17, 2020

Philippines begins nine-month clinical trial on Avigan in COVID-19 study

The Philippines started nine-month clinical trials for Avigan on Monday to study the efficacy of the Japanese anti-flu drug against the disease caused by the new coronavirus. Health Undersecretary Maria Rosario Vergeire said the clinical trials will include just four hospitals in Metro Manila initially ...

« 1 … 29 30 31 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times